Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8360 | 1192 | 30.7 | 56% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2068 | 4819 | BLOOD BRAIN BARRIER//SUICIDE TRANSPORT//INTRACAROTID CHEMOTHERAPY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTRACAROTID CHEMOTHERAPY | Author keyword | 15 | 88% | 1% | 7 |
2 | RMP 7 | Author keyword | 10 | 52% | 1% | 14 |
3 | INTRACAROTID INFUSION | Author keyword | 5 | 60% | 1% | 6 |
4 | BLOOD BRAIN BARRIER DISRUPTION | Author keyword | 5 | 24% | 2% | 20 |
5 | BLOOD TUMOR BARRIER | Author keyword | 5 | 26% | 1% | 15 |
6 | CEREPORT | Author keyword | 4 | 75% | 0% | 3 |
7 | BLOOD BRAIN TUMOR BARRIER | Author keyword | 4 | 56% | 0% | 5 |
8 | ACNU | Author keyword | 4 | 22% | 1% | 16 |
9 | INTRACAROTID | Author keyword | 4 | 46% | 1% | 6 |
10 | INTRACAROTID ADMINISTRATION | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTRACAROTID CHEMOTHERAPY | 15 | 88% | 1% | 7 | Search INTRACAROTID+CHEMOTHERAPY | Search INTRACAROTID+CHEMOTHERAPY |
2 | RMP 7 | 10 | 52% | 1% | 14 | Search RMP+7 | Search RMP+7 |
3 | INTRACAROTID INFUSION | 5 | 60% | 1% | 6 | Search INTRACAROTID+INFUSION | Search INTRACAROTID+INFUSION |
4 | BLOOD BRAIN BARRIER DISRUPTION | 5 | 24% | 2% | 20 | Search BLOOD+BRAIN+BARRIER+DISRUPTION | Search BLOOD+BRAIN+BARRIER+DISRUPTION |
5 | BLOOD TUMOR BARRIER | 5 | 26% | 1% | 15 | Search BLOOD+TUMOR+BARRIER | Search BLOOD+TUMOR+BARRIER |
6 | CEREPORT | 4 | 75% | 0% | 3 | Search CEREPORT | Search CEREPORT |
7 | BLOOD BRAIN TUMOR BARRIER | 4 | 56% | 0% | 5 | Search BLOOD+BRAIN+TUMOR+BARRIER | Search BLOOD+BRAIN+TUMOR+BARRIER |
8 | ACNU | 4 | 22% | 1% | 16 | Search ACNU | Search ACNU |
9 | INTRACAROTID | 4 | 46% | 1% | 6 | Search INTRACAROTID | Search INTRACAROTID |
10 | INTRACAROTID ADMINISTRATION | 3 | 100% | 0% | 3 | Search INTRACAROTID+ADMINISTRATION | Search INTRACAROTID+ADMINISTRATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRACAROTID INFUSION | 73 | 71% | 5% | 60 |
2 | BRADYKININ ANALOG | 34 | 69% | 2% | 29 |
3 | RMP 7 | 25 | 63% | 2% | 25 |
4 | METHOTREXATE DELIVERY | 21 | 78% | 1% | 14 |
5 | INTRACAROTID CHEMOTHERAPY | 20 | 100% | 1% | 9 |
6 | INTRA ARTERIAL BCNU | 15 | 88% | 1% | 7 |
7 | BCNU CHEMOTHERAPY | 13 | 71% | 1% | 10 |
8 | HYPEROSMOLAR MANNITOL | 12 | 86% | 1% | 6 |
9 | HIGH DOSE BCNU | 11 | 67% | 1% | 10 |
10 | BCNU | 11 | 19% | 4% | 53 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means | 1998 | 291 | 54 | 31% |
Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy | 2001 | 50 | 63 | 63% |
The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier - From concept to clinical evaluation | 2001 | 51 | 50 | 60% |
CHEMOTHERAPY FOR MALIGNANT GLIOMAS | 1988 | 255 | 58 | 55% |
Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review | 2014 | 1 | 17 | 76% |
OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION AND CHEMOTHERAPY IN THE TREATMENT OF HIGH-GRADE MALIGNANT GLIOMA - PATIENT SERIES AND LITERATURE-REVIEW | 1992 | 82 | 18 | 83% |
Recent advances in blood-brain barrier disruption as a CNS delivery strategy | 2008 | 43 | 42 | 40% |
Perioperative complications of blood brain barrier disruption under general anesthesia: A retrospective review | 2008 | 10 | 10 | 80% |
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide | 2013 | 11 | 134 | 21% |
RETINAL TOXICITIES OF CANCER THERAPY DRUGS Biologics, Small Molecule Inhibitors, and Chemotherapies | 2014 | 2 | 97 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WEILL CORNELL BRAIN TUMOR | 2 | 26% | 0.4% | 5 |
2 | NEUROL L603 | 1 | 100% | 0.2% | 2 |
3 | RADIOL IMAGING SCI PROGRAM | 1 | 40% | 0.2% | 2 |
4 | CLIN ONCOL RADIOTHER EUT | 1 | 50% | 0.1% | 1 |
5 | NIH SURG NEUROL BRANCH | 1 | 50% | 0.1% | 1 |
6 | PEDIAT CLIN SERV | 1 | 50% | 0.1% | 1 |
7 | SERV NEUROCHIRURG NEUROONCOL | 1 | 50% | 0.1% | 1 |
8 | SHENYANG COMMAND | 1 | 50% | 0.1% | 1 |
9 | UNITE TRANSPLANT MEDULLAIRE | 1 | 50% | 0.1% | 1 |
10 | ETIENNE LEBEL | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160712 | VASOGENIC BRAIN EDEMA//CEREBRAL VENULE//ENDOGENOUS ALBUMIN |
2 | 0.0000151452 | TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA |
3 | 0.0000148696 | CONVECTION ENHANCED DELIVERY//GLIADEL//CARMUSTINE WAFERS |
4 | 0.0000088758 | SERBSKY SOCIAL FORENS PSYCHIAT//BRAIN ADJACENT TO TUMOR//BRAIN TUMOR TISSUE BANK |
5 | 0.0000082757 | CELL MED//H 1 CELLS//H1 CELLS |
6 | 0.0000076463 | SARCNU//TAUROMUSTINE//S 2250 KAWAGISHI |
7 | 0.0000076286 | BRAIN TARGETING//SMART DRUG DELIVERY//ANGIOPEP 2 |
8 | 0.0000062734 | BBB//TRANSENDOTHELIAL ELECTRICAL RESISTANCE//PHYSIOPATHOL BARRIERE HEMATO ENCEPHAL |
9 | 0.0000058387 | BRAIN TUMOR PROGRAM//GLIOMA IMMUNOTHER Y GRP//GL261 |
10 | 0.0000055707 | EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS |